Cargando…

Targeted Deletion of Thymosin Beta 4 in Hepatic Stellate Cells Ameliorates Liver Fibrosis in a Transgenic Mouse Model

Liver fibrosis is the most common feature of liver disease, and activated hepatic stellate cells (HSCs) are the main contributors to liver fibrosis. Thus, finding key targets that modulate HSC activation is important to prevent liver fibrosis. Previously, we showed that thymosin β4 (Tβ4) influenced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jieun, Lee, Chanbin, Han, Jinsol, Jeong, Hayeong, Wang, Sihyung, Choi, Yung Hyun, Jung, Youngmi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297343/ https://www.ncbi.nlm.nih.gov/pubmed/37371128 http://dx.doi.org/10.3390/cells12121658

Ejemplares similares

Thymosin beta-4 regulates activation of hepatic stellate cells via hedgehog signaling
por: Kim, Jieun, et al.
Publicado: (2017)

Hepatic Stellate Cells Express Thymosin Beta 4 in Chronically Damaged Liver
por: Kim, Jieun, et al.
Publicado: (2015)

Mesenchymal Stem Cells Influence Activation of Hepatic Stellate Cells, and Constitute a Promising Therapy for Liver Fibrosis
por: Lee, Chanbin, et al.
Publicado: (2021)

Potential Role of Thymosin Beta 4 in Liver Fibrosis
por: Kim, Jieun, et al.
Publicado: (2015)

Tumor necrosis factor-inducible gene 6 interacts with CD44, which is involved in fate-change of hepatic stellate cells
por: Wang, Sihyung, et al.
Publicado: (2020)

sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p
por: Kim, Jieun, et al.
Publicado: (2021)

MicroRNA-378 is involved in hedgehog-driven epithelial-to-mesenchymal transition in hepatocytes of regenerating liver
por: Kim, Jieun, et al.
Publicado: (2018)

Tumor necrosis factor-inducible gene 6 protein ameliorates chronic liver damage by promoting autophagy formation in mice
por: Wang, Sihyung, et al.
Publicado: (2017)

Editorial Expression of Concern: Tumor necrosis factor-inducible gene 6 protein ameliorates chronic liver damage by promoting autophagy formation in mice
por: Wang, Sihyung, et al.
Publicado: (2021)

MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression
por: Hyun, Jeongeun, et al.
Publicado: (2016)

Deficiency of Formyl Peptide Receptor 2 Retards Hair Regeneration by Modulating the Activation of Hair Follicle Stem Cells and Dermal Papilla Cells in Mice
por: Han, Jinsol, et al.
Publicado: (2021)

Pathological Contribution of Extracellular Vesicles and Their MicroRNAs to Progression of Chronic Liver Disease
por: Lee, Chanbin, et al.
Publicado: (2022)

Formyl peptide receptor 2 is an emerging modulator of inflammation in the liver
por: Lee, Chanbin, et al.
Publicado: (2023)

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
por: Liu, Ya-Wei, et al.
Publicado: (2015)

Current Therapeutic Options and Potential of Mesenchymal Stem Cell Therapy for Alcoholic Liver Disease
por: Han, Jinsol, et al.
Publicado: (2022)

Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways
por: Choi, Jihye, et al.
Publicado: (2023)

Thymosin Beta 4 and Thymosin Beta 10 Expression in Hepatocellular Carcinoma
por: Theunissen, W., et al.
Publicado: (2014)

Pathophysiological Aspects of Alcohol Metabolism in the Liver
por: Hyun, Jeongeun, et al.
Publicado: (2021)

Thymosin Beta-4 Induces Mouse Hair Growth
por: Gao, Xiaoyu, et al.
Publicado: (2015)

Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis
por: Lee, Chanbin, et al.
Publicado: (2022)

Hepatoprotective Effect of Kombucha Tea in Rodent Model of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Lee, Chanbin, et al.
Publicado: (2019)

Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Lee, Chanbin, et al.
Publicado: (2019)

Immunoreactivity for Thymosin Beta 4 and Thymosin Beta 10 in the Adult Rat Oro-Gastro-Intestinal tract
por: Nemolato, S, et al.
Publicado: (2013)

Phloretin Ameliorates Succinate-Induced Liver Fibrosis by Regulating Hepatic Stellate Cells
por: Le, Cong Thuc, et al.
Publicado: (2023)

Gypenosides Synergistically Reduce the Extracellular Matrix of Hepatic Stellate Cells and Ameliorate Hepatic Fibrosis in Mice
por: Li, Han, et al.
Publicado: (2023)

Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection
por: Yu, Rui, et al.
Publicado: (2021)

Thymosin-β4 inhibits proliferation and induces apoptosis of hepatic stellate cells through PI3K/AKT pathway
por: Zhu, Lili, et al.
Publicado: (2017)

Genetic deletion of nitric oxide synthase 2 ameliorates Parkinson’s disease pathology and neuroinflammation in a transgenic mouse model of synucleinopathy
por: Kim, Jieun, et al.
Publicado: (2023)

MicroRNA Expression Profiling in CCl(4)-Induced Liver Fibrosis of Mus musculus
por: Hyun, Jeongeun, et al.
Publicado: (2016)

Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation
por: Guo, Ren, et al.
Publicado: (2022)

Eupatilin Ameliorates Hepatic Fibrosis and Hepatic Stellate Cell Activation by Suppressing β-catenin/PAI-1 Pathway
por: Hu, Jinyuan, et al.
Publicado: (2023)

Thymosin Beta 4 Is Involved in the Development of Electroacupuncture Tolerance
por: Wan, Juan, et al.
Publicado: (2019)

Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo
por: Li, Qinghua, et al.
Publicado: (2018)

Novel oral SPT inhibitor CH5169356 inhibits hepatic stellate cell activation and ameliorates hepatic fibrosis in mouse models of non‐alcoholic steatohepatitis (NASH)
por: Hada, Natsuko, et al.
Publicado: (2023)

Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis
por: Knorr, Jana, et al.
Publicado: (2023)

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
por: Schon, Hans-Theo, et al.
Publicado: (2016)

Expression pattern of thymosin beta 4 in the adult human liver
por: Nemolato, S., et al.
Publicado: (2011)

Thymosin beta4 sylphoxide: potential role in resolution of inflammation?
por: Young, JD, et al.
Publicado: (2001)

The Clinical Relevance and Functional Implications of Thymosin Beta-10 in Glioma
por: Li, Weimin, et al.
Publicado: (2023)

Hepatic stellate cells and parasite-induced liver fibrosis
por: Anthony, Barrie, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8p6f2hsae653lgr4cgjgh5omdp